生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | KN-62 exhibits strong antagonism against ATP-induced Ba2+ influx in fura-2-loaded human lymphocytes, with an IC50 of 12.7 nM and complete inhibition of the flux at a concentration of 500 nM[1]. KN-62 does not hinder the activity of autophosphorylated Ca2+/CaM kinase II. It dose-dependently inhibits the Ca2+/calmodulin-dependent autophosphorylation of both alpha (50 kDa) and beta (60 kDa) subunits of Ca2+/CaM kinase II in the presence or absence of exogenous substrate[2]. KN-62 in human leukemic B lymphocytes diminishes the rate of permeability increase to larger permeant cations, such as ethidium, induced by Bz-ATP, with an IC50 of 13.1 nM[4]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
HEK293 cells | Function assay | Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium influx, IC50=50.12 nM | 19191585 | ||
human lymphocytes | Function assay | Antagonist activity at P2X7 receptor in human lymphocytes assessed as inhibition of ATP-induced Ba2+ influx, IC50=12.59 nM | 19191585 | ||
THP1 cells | Function assay | Inhibition of Bz-ATP-induced IL1-beta release in LPS/IFN-gamma-differentiated human THP1 cells by ELISA, IC50=0.081 μM | 19110420 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.39mL 0.28mL 0.14mL |
6.93mL 1.39mL 0.69mL |
13.85mL 2.77mL 1.39mL |
参考文献 |
---|